Wells Fargo Private Biotech Symposium
November 2, 2022
, ** Virtual Meetings **
, New York, New York
Conference Coordinator: Monica Meehan
| Presenter Name | Ticker | Analyst Rating | Speakers | Country | Sector | Status | USD Marketcap | Category |
|---|---|---|---|---|---|---|---|---|
|
Affini-T Therapeutics, Inc.
|
Jak Knowles
,
Co-Founder, President and Chief Executive Officer
Loïc Vincent
,
CSO
Dirk Nagerson
,
Chief Medical Officer
Kim Nguyen
,
Chief Technical Officer
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
Arbor Biotechnologies Inc
|
Devyn Smith
,
CEO
Steven Favaloro
,
CFO
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
Aristea Therapeutics
|
James Mackay
,
President & CEO
Justin Thacker
,
CFO
DeAnne Reid
,
Sr. Director, Operations & Business Development
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
Dialectic Therapeutics
|
Biotechnology | Confirmed- 1x1/Group meetings | Cancelled | |||||
|
Flare Therapeutics
|
N/A |
Daphne Karydas
,
CFO
,
FLARE THERAPEUTICS
|
Biotechnology | Confirmed- 1x1/Group meetings | N/A | Presenting Company | ||
|
Immune-ONC Therapeutics, Inc.
|
Charlene Liao
,
CEO
Christopher Whitmore
,
CFO
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
Kyverna Therapeutics
|
, | N/A |
Dominic Borie
,
CEO
,
Kyverna Therapeutics
Julie Winter
,
VP Corporate Development
,
Kyverna Therapeutics
|
Biotechnology | Cancelled | N/A | Cancelled | |
|
Lacerta Therapeutics
|
Biotechnology | Cancelled | Presenting Company | |||||
|
Marengo Therapeutics
|
Zhen Su
,
CEO
Svetlana Makhni
,
CFO
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
Model Medicines
|
Daniel Haders
,
CEO
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
Myeloid Therapeutics, Inc.
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | |||
|
Neomorph
|
, | N/A |
Phil Chamberlain
,
Co-Founder, President, and CEO
,
Neomorph
Bell Zhong
,
CFO
,
Neomorph
Ana Grant
,
Executive Director, Data Sciences
,
Neomorph
Marla Bornstein
,
Vice President, Business Development
,
Neomorph
Mary Matyskiela
,
Vice President of Molecular Sciences
,
Neomorph
Rohan Beckwith
,
Vice President, Chemistry
,
Neomorph
|
Biotechnology | Confirmed- 1x1/Group meetings | N/A | Presenting Company | |
|
Sitryx Therapeutics Ltd.
|
Neil Weir
,
CEO
Jonathan Senior
,
CFO
Ravi Rao
,
CMO
Iain Kilty
,
CSO
|
United Kingdom | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
Triumvira Immunologics
|
Paul Lammers
,
CEO
Teresa McRoberts
,
CFO
|
United States | Biotechnology | Confirmed- 1x1/Group meetings | 0 | Presenting Company | ||
|
ValenzaBio
|
Biotechnology | Confirmed- 1x1/Group meetings | Cancelled |
